Targeting RET Solvent-Front Mutants with Alkynyl Nicotinamide-Based Inhibitors.
Khatri U, Dayal N, Hu X, Larocque E, Naganna N, Shen T, Liu X, Holtsberg FW, Aman MJ, Sintim HO, Wu J.
Khatri U, et al.
Mol Cancer Ther. 2023 Jun 1;22(6):717-725. doi: 10.1158/1535-7163.MCT-22-0629.
Mol Cancer Ther. 2023.
PMID: 37070927
Free PMC article.